Where can I listen to this podcast?

This podcast is available on 4 platforms including Apple Podcasts, Spotify, and more. You can also use the RSS feed directly.

Does this podcast accept guests?

Yes, this podcast regularly features guests.

NCIMI Voices

Claim This Podcast

by NCIMI Voices

6 episodes

Updated Daily

Accepts GuestsHas SponsorsLocation 🇬🇧

Podcast Overview

Expert insights on the future of AI and healthcare. Welcome to a new series by NCIMI – the National Consortium for Intelligent Medical Imaging. Join Claire Bloomfield, CEO of NCIMI, and a range of experts from across the UK to explore the opportunities for artificial intelligence in healthcare. We work with innovating companies from the medi-tech industry, leading consultants and clinicians at NHS trusts across the UK, plus charities and patient groups to explore what AI could to do to improve both diagnosis and treatment of a range of conditions. Thank you to our funders, Innovate UK.

Language

🇺🇲

Publishing Since

1/16/2020

Visit Website View on Apple Podcasts RSS Feed

1 verified contact email on file for NCIMI Voices

Pitch yourself as a guest, propose sponsorships, or reach out directly to the host.

See contact details

Recent Episodes

May 17, 2021

NCIMI Voices Episode 6: AI and lung health – Detecting lung nodules and beyond

On this episode of NCIMI Voices, we celebrate advances in algorithms for detecting early stage lung cancer. Claire Bloomfield speaks with by Prof Fergus Gleeson, NCIMI's Chief Medical Officer and chief investigator for the DART research programme. They are joined by Optellum's CEO Václav Potěšil who talks about the company's recent FDA clearance in the US for Virtual Nodule Clinic to detect potentially cancerous nodules (small lesions) on lungs. We cover: -  Fergus on the DART programme for lung health and how it works with Optellum as a partner. -  Václav explains how their AI algorithm supports workflow and accurate decision making in a clinical setting. -  Václav explaining why FDA clearance for Optellum’s Virtual Nodule Clinic is “The biggest milestone in the history of our company”. -  How has Covid 19 impacted diagnosis and treatment of lung cancer? How could AI help support workflow? -  Where are we heading next? Optellum’s vision for CE marking and wider lung health to enable patients to be diagnosed and doctors to make optimum decisions for treatment to radically improve patient outcomes. About DART About Optellum <a href="https://optellum.com/" rel="noreferrer noopener" target="_blank">Optellum</a> is a lung health company, providing artificial intelligence software for clinicians to make the best decisions for early diagnosis and optimal treatment for every patient. Optellum was founded so that every lung disease patient is diagnosed and treated at the earliest possible stage, and cured. The company’s vision is to redefine early intervention of diseases like lung cancer, by enabling every clinician, in every hospital, to make the right decisions and give their patients the best chance to fight back. Optellum’s Virtual Nodule Clinic is the first clinical decision support software for personalised early diagnosis and treatment of lung cancer, based on artificial intelligence (AI) and machine learning applied to the world’s largest clinical dataset. <a href="https://optellum.com/">https://optellum.com</a> <a href="https://twitter.com/Optellum">https://twitter.com/Optellum</a> <a href="https://www.linkedin.com/company/optellum">https://www.linkedin.com/company/optellum</a> Thanks to our funders, Innovate UK. Check out our BRAND NEW WEBSITE! <a href="https://ncimi.co.uk/" title="https://ncimi.co.uk/">https://ncimi.co.uk/</a> Follow Claire on <a href="https://www.linkedin.com/in/claire-bloomfield-b499a654/" target="_blank">LinkedIn</a> Follow us on <a href="https://twitter.com/NCIMImaging" target="_blank">Twitter:</a> @NCIMImaging

January 25, 2021

NCIMI Voices Episode 5: Pivoting Through 2020 with GE Healthcare

2020 was a challenging year for the NCIMI team and its partners. In this mini series, CEO Claire Bloomfield talks to partners who have stepped up to the challenge during 2020 and continue to do so in 2021. In part two, Claire is joined by John Kalafut – Chief scientist for digital/informatics research at GE Healthcare. He describes himself as: “A real, driven innovator that loves to find and push boundaries in large and small organizations. I am very good at finding routes and paths through multi-dimensional problems requiring a blend of healthcare domain, scientific, computational, and product development acumen. I’m most proud of the projects and efforts that are now used in clinical practice around the world.” They discuss: -  Missing seeing each other face to face to create ideas and collaborate -  Trusting AI to take the place of a human in a busy clinic -  How to choose the right tech for the patient -  The end game – how AI tech is having a positive impact and improving patient wellbeing -  Challenges of working with a hardworking, stretched health care sector in the UK. -  Innovating the workflow for AI and healthcare -  First Vs next generations of AI application in medical imaging Thanks to our funders, Innovate UK. Check out the current NCIMI website <a href="https://www.medsci.ox.ac.uk/research/networks/national-consortium-of-intelligent-medical-imaging" target="_blank">here</a> Follow Claire on <a href="https://www.linkedin.com/in/claire-bloomfield-b499a654/" target="_blank">LinkedIn</a> John on <a href=" https://www.linkedin.com/in/johnnykpgh/">LinkedIn</a>  Follow us on <a href="https://twitter.com/NCIMImaging" target="_blank">Twitter:</a> @NCIMImaging

December 9, 2020

NCIMI Voices Episode 4: Pivoting Through 2020 with Perspectum

This year has been a challenging one, and for the NCIMI team it's been no different. In this mini series, CEO Claire Bloomfield talks to partners who have stepped up to the challenge during 2020. She is joined by one of NCIMI's founding partners, Rajarshi Banerjee, known to all as Banjo. Banjo is CEO of <a href="https://perspectum.com/">Perspectum</a> and consultant in cardiology and internal medicine. Perspectum was established in 2012 to develop new MR technologies and software to detect liver disease and disorders more accurately. We discuss: -  Is Radiology in need of a rebrand? -  What’s the role of a radiologist going to look like in the future? -  'Dumb' imaging V intelligent imaging -  The future of smart imaging in diagnosis and treatment -  How Perspectum is innovating to generate new smart imaging tools. Thanks to our funders, Innovate UK, and look out for our new website coming soon at the end of December. Check out the current NCIM website <a href="https://www.medsci.ox.ac.uk/research/networks/national-consortium-of-intelligent-medical-imaging" rel="ugc noopener noreferrer" target="_blank">here</a> Follow Claire on <a href="https://www.linkedin.com/in/claire-bloomfield-b499a654/" rel="ugc noopener noreferrer" target="_blank">LinkedIn</a> Banjo on <a href="https://www.linkedin.com/in/rajarshi-banerjee-08957580/?originalSubdomain=uk">LinkedIn</a> Follow us on <a href="https://twitter.com/NCIMImaging" rel="ugc noopener noreferrer" target="_blank">Twitter:</a> @NCIMImaging Follow Perspectum on <a href="https://twitter.com/PerspectumGroup">Twitter</a> @PerspectumGroup

6 total episodes available

Deep-dive analytics for NCIMI Voices

Frequently asked questions

Have a different question and can't find the answer you're looking for? Reach out to our support team by sending us an email and we'll get back to you as soon as we can.

What is NCIMI Voices?: Expert insights on the future of AI and healthcare.

Welcome to a new series by NCIMI – the National Consortium for Intelligent Medical Imaging.

Join Claire Bloomfield, CEO of NCIMI, and a range of experts from across the UK to explore the opportunities for artificial intelligence in healthcare.

We work with innovating companies from the medi-tech industry, leading consultants and clinicians at NHS trusts across the UK, plus charities and patient groups to explore what AI could to do to improve both diagnosis and treatment of a range of conditions.

Thank you to our funders, Innovate UK.
How often does this podcast release new episodes?: This podcast updates daily.
Where can I listen to this podcast?: This podcast is available on 4 platforms including Apple Podcasts, Spotify, and more. You can also use the RSS feed directly.
Does this podcast accept guests?: Yes, this podcast regularly features guests.

Legal Disclaimer

Pod Engine is not affiliated with, endorsed by, or officially connected with any of the podcasts displayed on this platform. We operate independently as a podcast discovery and analytics service.

All podcast artwork, thumbnails, and content displayed on this page are the property of their respective owners and are protected by applicable copyright laws. This includes, but is not limited to, podcast cover art, episode artwork, show descriptions, episode titles, transcripts, audio snippets, and any other content originating from the podcast creators or their licensors.

We display this content under fair use principles and/or implied license for the purpose of podcast discovery, information, and commentary. We make no claim of ownership over any podcast content, artwork, or related materials shown on this platform. All trademarks, service marks, and trade names are the property of their respective owners.

While we strive to ensure all content usage is properly authorized, if you are a rights holder and believe your content is being used inappropriately or without proper authorization, please contact us immediately at hey@podengine.ai for prompt review and appropriate action, which may include content removal or proper attribution.

By accessing and using this platform, you acknowledge and agree to respect all applicable copyright laws and intellectual property rights of content owners. Any unauthorized reproduction, distribution, or commercial use of the content displayed on this platform is strictly prohibited.